The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Duloxetine, sold under the brand name Cymbalta among others, is a medication mostly used for major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain.
The global Duloxetine market was valued at US$ 209 million in 2023 and is anticipated to reach US$ 279.3 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.
Duloxetine is a medication used primarily to treat major depressive disorder, generalized anxiety disorder, and chronic pain conditions such as fibromyalgia and neuropathic pain. The market for duloxetine is driven by several factors. Depression and anxiety are common mental health disorders affecting a significant percentage of the population worldwide. The growing prevalence of these disorders is one of the key drivers of the duloxetine market. As awareness about mental health and the availability of treatment options increases, more and more patients are seeking medical help for their depression and anxiety. This heightened awareness has driven demand for medications like duloxetine. Chronic pain conditions like fibromyalgia and neuropathic pain are a growing healthcare concern. Duloxetine has been approved by the FDA for use in managing several chronic pain conditions, which has driven its market growth. The elderly population is more susceptible to depression, anxiety, and chronic pain conditions. With the aging of the baby boomer generation, there is a greater demand for medications like duloxetine. While duloxetine is effective in treating depression, anxiety, and chronic pain, there are other medications available in the market for managing these conditions. Competing medications can drive innovation and further demand for duloxetine.
This report aims to provide a comprehensive presentation of the global market for Duloxetine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duloxetine.
Report Scope
The Duloxetine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Duloxetine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Duloxetine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Teva
Lupin
Sun Pharma
Zydus Pharmaceuticals
Torrent Pharmaceuticals
Aurobindo Pharma
Apotex
Breckenridge
MACLEODS
Ajanta Pharma
CSPC Ouyi Pharm
Jiangsu Nhwa Pharmaceutical
Segment by Type
20mg Capsules
30mg Capsules
40mg Capsules
60mg Capsules
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Duloxetine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Duloxetine, sold under the brand name Cymbalta among others, is a medication mostly used for major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain.
The global Duloxetine market was valued at US$ 209 million in 2023 and is anticipated to reach US$ 279.3 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.
Duloxetine is a medication used primarily to treat major depressive disorder, generalized anxiety disorder, and chronic pain conditions such as fibromyalgia and neuropathic pain. The market for duloxetine is driven by several factors. Depression and anxiety are common mental health disorders affecting a significant percentage of the population worldwide. The growing prevalence of these disorders is one of the key drivers of the duloxetine market. As awareness about mental health and the availability of treatment options increases, more and more patients are seeking medical help for their depression and anxiety. This heightened awareness has driven demand for medications like duloxetine. Chronic pain conditions like fibromyalgia and neuropathic pain are a growing healthcare concern. Duloxetine has been approved by the FDA for use in managing several chronic pain conditions, which has driven its market growth. The elderly population is more susceptible to depression, anxiety, and chronic pain conditions. With the aging of the baby boomer generation, there is a greater demand for medications like duloxetine. While duloxetine is effective in treating depression, anxiety, and chronic pain, there are other medications available in the market for managing these conditions. Competing medications can drive innovation and further demand for duloxetine.
This report aims to provide a comprehensive presentation of the global market for Duloxetine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duloxetine.
Report Scope
The Duloxetine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Duloxetine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Duloxetine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Teva
Lupin
Sun Pharma
Zydus Pharmaceuticals
Torrent Pharmaceuticals
Aurobindo Pharma
Apotex
Breckenridge
MACLEODS
Ajanta Pharma
CSPC Ouyi Pharm
Jiangsu Nhwa Pharmaceutical
Segment by Type
20mg Capsules
30mg Capsules
40mg Capsules
60mg Capsules
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Duloxetine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Duloxetine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 20mg Capsules
1.2.3 30mg Capsules
1.2.4 40mg Capsules
1.2.5 60mg Capsules
1.3 Market by Application
1.3.1 Global Duloxetine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Duloxetine Market Perspective (2019-2030)
2.2 Duloxetine Growth Trends by Region
2.2.1 Global Duloxetine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Duloxetine Historic Market Size by Region (2019-2024)
2.2.3 Duloxetine Forecasted Market Size by Region (2025-2030)
2.3 Duloxetine Market Dynamics
2.3.1 Duloxetine Industry Trends
2.3.2 Duloxetine Market Drivers
2.3.3 Duloxetine Market Challenges
2.3.4 Duloxetine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Duloxetine Players by Revenue
3.1.1 Global Top Duloxetine Players by Revenue (2019-2024)
3.1.2 Global Duloxetine Revenue Market Share by Players (2019-2024)
3.2 Global Duloxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Duloxetine Revenue
3.4 Global Duloxetine Market Concentration Ratio
3.4.1 Global Duloxetine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Duloxetine Revenue in 2023
3.5 Duloxetine Key Players Head office and Area Served
3.6 Key Players Duloxetine Product Solution and Service
3.7 Date of Enter into Duloxetine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Duloxetine Breakdown Data by Type
4.1 Global Duloxetine Historic Market Size by Type (2019-2024)
4.2 Global Duloxetine Forecasted Market Size by Type (2025-2030)
5 Duloxetine Breakdown Data by Application
5.1 Global Duloxetine Historic Market Size by Application (2019-2024)
5.2 Global Duloxetine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Duloxetine Market Size (2019-2030)
6.2 North America Duloxetine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Duloxetine Market Size by Country (2019-2024)
6.4 North America Duloxetine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Duloxetine Market Size (2019-2030)
7.2 Europe Duloxetine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Duloxetine Market Size by Country (2019-2024)
7.4 Europe Duloxetine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Duloxetine Market Size (2019-2030)
8.2 Asia-Pacific Duloxetine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Duloxetine Market Size by Region (2019-2024)
8.4 Asia-Pacific Duloxetine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Duloxetine Market Size (2019-2030)
9.2 Latin America Duloxetine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Duloxetine Market Size by Country (2019-2024)
9.4 Latin America Duloxetine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Duloxetine Market Size (2019-2030)
10.2 Middle East & Africa Duloxetine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Duloxetine Market Size by Country (2019-2024)
10.4 Middle East & Africa Duloxetine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Duloxetine Introduction
11.1.4 Eli Lilly Revenue in Duloxetine Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Duloxetine Introduction
11.2.4 Teva Revenue in Duloxetine Business (2019-2024)
11.2.5 Teva Recent Development
11.3 Lupin
11.3.1 Lupin Company Detail
11.3.2 Lupin Business Overview
11.3.3 Lupin Duloxetine Introduction
11.3.4 Lupin Revenue in Duloxetine Business (2019-2024)
11.3.5 Lupin Recent Development
11.4 Sun Pharma
11.4.1 Sun Pharma Company Detail
11.4.2 Sun Pharma Business Overview
11.4.3 Sun Pharma Duloxetine Introduction
11.4.4 Sun Pharma Revenue in Duloxetine Business (2019-2024)
11.4.5 Sun Pharma Recent Development
11.5 Zydus Pharmaceuticals
11.5.1 Zydus Pharmaceuticals Company Detail
11.5.2 Zydus Pharmaceuticals Business Overview
11.5.3 Zydus Pharmaceuticals Duloxetine Introduction
11.5.4 Zydus Pharmaceuticals Revenue in Duloxetine Business (2019-2024)
11.5.5 Zydus Pharmaceuticals Recent Development
11.6 Torrent Pharmaceuticals
11.6.1 Torrent Pharmaceuticals Company Detail
11.6.2 Torrent Pharmaceuticals Business Overview
11.6.3 Torrent Pharmaceuticals Duloxetine Introduction
11.6.4 Torrent Pharmaceuticals Revenue in Duloxetine Business (2019-2024)
11.6.5 Torrent Pharmaceuticals Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Detail
11.7.2 Aurobindo Pharma Business Overview
11.7.3 Aurobindo Pharma Duloxetine Introduction
11.7.4 Aurobindo Pharma Revenue in Duloxetine Business (2019-2024)
11.7.5 Aurobindo Pharma Recent Development
11.8 Apotex
11.8.1 Apotex Company Detail
11.8.2 Apotex Business Overview
11.8.3 Apotex Duloxetine Introduction
11.8.4 Apotex Revenue in Duloxetine Business (2019-2024)
11.8.5 Apotex Recent Development
11.9 Breckenridge
11.9.1 Breckenridge Company Detail
11.9.2 Breckenridge Business Overview
11.9.3 Breckenridge Duloxetine Introduction
11.9.4 Breckenridge Revenue in Duloxetine Business (2019-2024)
11.9.5 Breckenridge Recent Development
11.10 MACLEODS
11.10.1 MACLEODS Company Detail
11.10.2 MACLEODS Business Overview
11.10.3 MACLEODS Duloxetine Introduction
11.10.4 MACLEODS Revenue in Duloxetine Business (2019-2024)
11.10.5 MACLEODS Recent Development
11.11 Ajanta Pharma
11.11.1 Ajanta Pharma Company Detail
11.11.2 Ajanta Pharma Business Overview
11.11.3 Ajanta Pharma Duloxetine Introduction
11.11.4 Ajanta Pharma Revenue in Duloxetine Business (2019-2024)
11.11.5 Ajanta Pharma Recent Development
11.12 CSPC Ouyi Pharm
11.12.1 CSPC Ouyi Pharm Company Detail
11.12.2 CSPC Ouyi Pharm Business Overview
11.12.3 CSPC Ouyi Pharm Duloxetine Introduction
11.12.4 CSPC Ouyi Pharm Revenue in Duloxetine Business (2019-2024)
11.12.5 CSPC Ouyi Pharm Recent Development
11.13 Jiangsu Nhwa Pharmaceutical
11.13.1 Jiangsu Nhwa Pharmaceutical Company Detail
11.13.2 Jiangsu Nhwa Pharmaceutical Business Overview
11.13.3 Jiangsu Nhwa Pharmaceutical Duloxetine Introduction
11.13.4 Jiangsu Nhwa Pharmaceutical Revenue in Duloxetine Business (2019-2024)
11.13.5 Jiangsu Nhwa Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Duloxetine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 20mg Capsules
Table 3. Key Players of 30mg Capsules
Table 4. Key Players of 40mg Capsules
Table 5. Key Players of 60mg Capsules
Table 6. Global Duloxetine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Duloxetine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Duloxetine Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Duloxetine Market Share by Region (2019-2024)
Table 10. Global Duloxetine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Duloxetine Market Share by Region (2025-2030)
Table 12. Duloxetine Market Trends
Table 13. Duloxetine Market Drivers
Table 14. Duloxetine Market Challenges
Table 15. Duloxetine Market Restraints
Table 16. Global Duloxetine Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Duloxetine Market Share by Players (2019-2024)
Table 18. Global Top Duloxetine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duloxetine as of 2023)
Table 19. Ranking of Global Top Duloxetine Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Duloxetine Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Duloxetine Product Solution and Service
Table 23. Date of Enter into Duloxetine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Duloxetine Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Duloxetine Revenue Market Share by Type (2019-2024)
Table 27. Global Duloxetine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Duloxetine Revenue Market Share by Type (2025-2030)
Table 29. Global Duloxetine Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Duloxetine Revenue Market Share by Application (2019-2024)
Table 31. Global Duloxetine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Duloxetine Revenue Market Share by Application (2025-2030)
Table 33. North America Duloxetine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Duloxetine Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Duloxetine Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Duloxetine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Duloxetine Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Duloxetine Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Duloxetine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Duloxetine Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Duloxetine Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Duloxetine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Duloxetine Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Duloxetine Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Duloxetine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Duloxetine Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Duloxetine Market Size by Country (2025-2030) & (US$ Million)
Table 48. Eli Lilly Company Detail
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Duloxetine Product
Table 51. Eli Lilly Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Teva Company Detail
Table 54. Teva Business Overview
Table 55. Teva Duloxetine Product
Table 56. Teva Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 57. Teva Recent Development
Table 58. Lupin Company Detail
Table 59. Lupin Business Overview
Table 60. Lupin Duloxetine Product
Table 61. Lupin Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 62. Lupin Recent Development
Table 63. Sun Pharma Company Detail
Table 64. Sun Pharma Business Overview
Table 65. Sun Pharma Duloxetine Product
Table 66. Sun Pharma Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 67. Sun Pharma Recent Development
Table 68. Zydus Pharmaceuticals Company Detail
Table 69. Zydus Pharmaceuticals Business Overview
Table 70. Zydus Pharmaceuticals Duloxetine Product
Table 71. Zydus Pharmaceuticals Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 72. Zydus Pharmaceuticals Recent Development
Table 73. Torrent Pharmaceuticals Company Detail
Table 74. Torrent Pharmaceuticals Business Overview
Table 75. Torrent Pharmaceuticals Duloxetine Product
Table 76. Torrent Pharmaceuticals Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 77. Torrent Pharmaceuticals Recent Development
Table 78. Aurobindo Pharma Company Detail
Table 79. Aurobindo Pharma Business Overview
Table 80. Aurobindo Pharma Duloxetine Product
Table 81. Aurobindo Pharma Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 82. Aurobindo Pharma Recent Development
Table 83. Apotex Company Detail
Table 84. Apotex Business Overview
Table 85. Apotex Duloxetine Product
Table 86. Apotex Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 87. Apotex Recent Development
Table 88. Breckenridge Company Detail
Table 89. Breckenridge Business Overview
Table 90. Breckenridge Duloxetine Product
Table 91. Breckenridge Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 92. Breckenridge Recent Development
Table 93. MACLEODS Company Detail
Table 94. MACLEODS Business Overview
Table 95. MACLEODS Duloxetine Product
Table 96. MACLEODS Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 97. MACLEODS Recent Development
Table 98. Ajanta Pharma Company Detail
Table 99. Ajanta Pharma Business Overview
Table 100. Ajanta Pharma Duloxetine Product
Table 101. Ajanta Pharma Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 102. Ajanta Pharma Recent Development
Table 103. CSPC Ouyi Pharm Company Detail
Table 104. CSPC Ouyi Pharm Business Overview
Table 105. CSPC Ouyi Pharm Duloxetine Product
Table 106. CSPC Ouyi Pharm Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 107. CSPC Ouyi Pharm Recent Development
Table 108. Jiangsu Nhwa Pharmaceutical Company Detail
Table 109. Jiangsu Nhwa Pharmaceutical Business Overview
Table 110. Jiangsu Nhwa Pharmaceutical Duloxetine Product
Table 111. Jiangsu Nhwa Pharmaceutical Revenue in Duloxetine Business (2019-2024) & (US$ Million)
Table 112. Jiangsu Nhwa Pharmaceutical Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Duloxetine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Duloxetine Market Share by Type: 2023 VS 2030
Figure 3. 20mg Capsules Features
Figure 4. 30mg Capsules Features
Figure 5. 40mg Capsules Features
Figure 6. 60mg Capsules Features
Figure 7. Global Duloxetine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Duloxetine Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Drug store Case Studies
Figure 11. Duloxetine Report Years Considered
Figure 12. Global Duloxetine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Duloxetine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Duloxetine Market Share by Region: 2023 VS 2030
Figure 15. Global Duloxetine Market Share by Players in 2023
Figure 16. Global Top Duloxetine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duloxetine as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Duloxetine Revenue in 2023
Figure 18. North America Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Duloxetine Market Share by Country (2019-2030)
Figure 20. United States Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Duloxetine Market Share by Country (2019-2030)
Figure 24. Germany Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Duloxetine Market Share by Region (2019-2030)
Figure 32. China Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Duloxetine Market Share by Country (2019-2030)
Figure 40. Mexico Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Duloxetine Market Share by Country (2019-2030)
Figure 44. Turkey Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Duloxetine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Eli Lilly Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 47. Teva Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 48. Lupin Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 49. Sun Pharma Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 50. Zydus Pharmaceuticals Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 51. Torrent Pharmaceuticals Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 52. Aurobindo Pharma Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 53. Apotex Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 54. Breckenridge Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 55. MACLEODS Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 56. Ajanta Pharma Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 57. CSPC Ouyi Pharm Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 58. Jiangsu Nhwa Pharmaceutical Revenue Growth Rate in Duloxetine Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
